← Browse by Condition
Medical Condition

preoperative

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT05613478 Phase 3
Recruiting

Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of Hepatocellular Carcinoma

Enrollment
130 pts
Location
China
Sponsor
The First Affiliated Hospital ...
View Trial →